AI assistant
RESMED INC — Director's Dealing 2022
Nov 14, 2022
30071_dirs_2022-11-14_07f2d2b9-17f3-4380-af67-e8b0250ae5bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-11-10
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-10 | ResMed Common Stock | G | 1000 | — | Disposed | 4090 | Indirect |
| 2022-11-10 | ResMed Common Stock | G | 1000 | — | Acquired | 4880 | Indirect |
| 2022-11-10 | ResMed Common Stock | S | 4880 | $220.83 | Disposed | 0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 422654 | Direct |
Footnotes
F1: Gift of shares transferred to The Lisette and Michael Farrell Foundation, Mr. Farrell retains dispositive power over remaining shares.
F2: Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares.
F3: This transaction was executed in multiple trades at prices ranging from $220.67 $220.97. The price reported above reflects the weighted average sale price.
F4: Includes 84.179 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.